2009.03~2012.04 육군 군의관(36사단 108연대 의무중대장, 육군훈련소 지구병원 안과)
2004.03~2009.02 건양대학교병원 인턴, 레지던트
학회활동
아주대학교병원 임상강사
연구업적
2019.05Age-related differences in the prevalence of subtypes of Neovascular age-related macular degeneration in the first diagnosed eye.
[Graefes Arch Clin Exp Ophthalmol]
2019.05Age-related differences in the prevalence of subtypes of Neovascularage-related macular degeneration in the first diagnosed eye
[Graefe's Archive for Clinical and Experimental Ophthalmology]
2019.04Long-term incidence and timing of reactivation in patients with type 3 neovascularization after initial treatment
[Graefes Arch Clin Exp Ophthalmol]
2019.03Abrupt visual loss during anti-vascular endothelial growth factor treatment for type 3 neovascularization.
[Int J Ophthalmol]
2019.03Abrupt visual loss during anti-vascular endothelialgrowth factor treatment for type 3 neovascularization
[Int J Ophthalmol]
2019.02CHARACTERISTICS OF TYPE 3 NEOVASCULARIZATION LESIONS: Focus on the Incidence of Multifocal Lesions and the Distribution of Lesion Location
[Retina]
2018.12DIFFERENCE IN TREATMENT OUTCOMES ACCORDING TO OPTICAL COHERENCE TOMOGRAPHY-BASED STAGES IN TYPE 3 NEOVASCULARIZATION (RETINAL ANGIOMATOUS PROLIFERATION).
[Retina]
2018.12DIFFERENCE IN TREATMENT OUTCOMESACCORDING TO OPTICAL COHERENCETOMOGRAPHY?BASED STAGES IN TYPE3 NEOVASCULARIZATION (RETINALANGIOMATOUS PROLIFERATION)
[RETINA]
2018.11MORPHOLOGIC FEATURES ASSOCIATED WITH FIBROTIC SCARRING AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN POLYPOIDAL CHOROIDAL VASCULOPATHY.
[Retina]
2018.11Prechoroidal Cleft in Type 3 Neovascularization: Incidence, Timing, and Its Association with Visual Outcome
[JOURNAL OF OPHTHALMOLOGY]
2018.11MORPHOLOGIC FEATURES ASSOCIATEDWITH FIBROTIC SCARRING AFTER ANTI?VASCULAR ENDOTHELIAL GROWTHFACTOR THERAPY IN POLYPOIDALCHOROIDAL VASCULOPATHY
[RETINA]
2018.11Prechoroidal Cleft in Type 3 Neovascularization: Incidence, Timing, and Its Association with Visual Outcome.
[J Ophthalmol]
2018.10Development of Submacular Hemorrhage in Neovascular Age-related Macular Degeneration: Influence on Visual Prognosis in a Clinical Setting.
[Korean J Ophthalmol]
2018.08Early Recurrent Hemorrhage in Submacular Hemorrhage Secondary to Type 3 Neovascularization or Retinal Angiomatous Proliferation: Incidence and Influence on Visual Prognosis
[SEMINARS IN OPHTHALMOLOGY]
2018.07LONG-TERM VISUAL CHANGES IN INITIALLY STRONGER FELLOW EYES IN PATIENTS WITH UNILATERAL TYPE 3 NEOVASCULARIZATION.
[Retina]
2018.03Hyperpigmented spots after treatment for submacular hemorrhage secondary to polypoidal choroidal vasculopathy
[Graefes Arch Clin Exp Ophthalmol]
2018.03Hyperpigmented spots after treatment for submacular hemorrhage secondary to polypoidal choroidal vasculopathy
[GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY]
2018.01Quantification of retinal changes after resolution of submacular hemorrhage secondary to polypoidal choroidal vasculopathy
[Jpn J Ophthalmol]
2018.01Quantification of retinal changes after resolution of submacular hemorrhage secondary to polypoidal choroidal vasculopathy
[JAPANESE JOURNAL OF OPHTHALMOLOGY]
2018.01Long-Term Outcomes in Patients with Neovascular Age-Related Macular Degeneration Who Maintain Dry Macula after Three Monthly Ranibizumab Injections
[SEMINARS IN OPHTHALMOLOGY]
2018Long-Term Outcomes in Patients with Neovascular Age-Related Macular Degeneration Who Maintain Dry Macula after Three Monthly Ranibizumab Injections.
[Semin Ophthalmol]
2018Early Recurrent Hemorrhage in Submacular Hemorrhage Secondary to Type 3 Neovascularization or Retinal Angiomatous Proliferation: Incidence and Influence on Visual Prognosis.
[Semin Ophthalmol]
2017.12NATURAL COURSE OF PATIENTS DISCONTINUING TREATMENT FOR AGE-RELATED MACULAR DEGENERATION AND FACTORS ASSOCIATED WITH VISUAL PROGNOSIS
[Retina]
2017.12NATURAL COURSE OF PATIENTS DISCONTINUING TREATMENT FOR AGE-RELATED MACULAR DEGENERATION AND FACTORS ASSOCIATED WITH VISUAL PROGNOSIS
[RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES]
2017.08RECURRENCE IN PATIENTS WITH TYPE 3 NEOVASCULARIZATION (RETINAL ANGIOMATOUS PROLIFERATION) AFTER INTRAVITREAL RANIBIZUMAB.
[Retina]
2017.08RECURRENCE IN PATIENTS WITH TYPE 3 NEOVASCULARIZATION (RETINAL ANGIOMATOUS PROLIFERATION) AFTER INTRAVITREAL RANIBIZUMAB
[RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES]
2017.07Incidence and Timing of the First Recurrence in Neovascular Age-Related Macular Degeneration: Comparison Between Ranibizumab and Aflibercept.
[J Ocul Pharmacol Ther]
2017.06Treatment of Bilateral Retinal Angiomatous Proliferation with Anti-vascular Endothelial Growth Factor: 12-Month Outcome
[Korean J Ophthalmol]
2017.06Treatment of Bilateral Retinal Angiomatous Proliferation with Anti-vascular Endothelial Growth Factor: 12-Month Outcome
[Korean Journal of Ophthalmology]
2017.06Polypoidal Choroidal Vasculopathy with Feeder Vessels: Characteristics, Fellow Eye Findings, and Long-term Treatment Outcomes
[Korean Journal of Ophthalmology]
2017.06Polypoidal Choroidal Vasculopathy with Feeder Vessels: Characteristics, Fellow Eye Findings, and Long-term Treatment Outcomes
[Korean J Ophthalmol]
2017.05Characteristics of Submacular Hemorrhages in Age-Related Macular Degeneration
[Optom Vis Sci]
2017.05Characteristics of Submacular Hemorrhages in Age-Related Macular Degeneration
[OPTOMETRY AND VISION SCIENCE]
2017.04특발망막전막에서 유리체절제술 전후 망막층별 두께변화와 시력예후와의 관계
[대한안과학회지]
2017.01Incidence and Timing of the First Recurrence in Neovascular Age-Related Macular Degeneration: Comparison Between Ranibizumab and Aflibercept
[JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS]
2017.01라니비주맙 치료에 반응이 제한적인 습성황반변성에서 3회 애플리버셉트 주입술의 효과
[대한안과학회지]
2017라니비주맙 치료에 반응이 제한적인 습성황반변성에서 3회 애플리버셉트 주입술의 효과
[한안지]
2017특발망막전막에서 유리체절제술 전후 망막층별 두께변화와 시력예후와의 관계
[한안지]
2016.12Short-term choroidal thickness changes in patients treated with either ranibizumab or aflibercept: a comparative study
[BRITISH JOURNAL OF OPHTHALMOLOGY]
2016.11Twelve-month outcomes of treatment using ranibizumab or aflibercept for neovascular age-related macular degeneration: a comparative study.
[Graefes Arch Clin Exp Ophthalmol]
2016.11Radiating hemorrhage in exudative age-related macular degeneration
[JAPANESE JOURNAL OF OPHTHALMOLOGY]
2016.11Twelve-month outcomes of treatment using ranibizumab or aflibercept for neovascular age-related macular degeneration: a comparative study
[GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY]
2016.10당뇨망막병증 환자에서 플루레신 형광안저조영술이 신기능에 미치는 영향
[대한안과학회지]
2016.09Long-Term Outcome and Recurrence of Idiopathic Choroidal Neovascularization Treated with Intravitreal Bevacizumab.
[J Ocul Pharmacol Ther]
2016.08DIAGNOSIS OF TYPE 3 NEOVASCULARIZATION BASED ON OPTICAL COHERENCE TOMOGRAPHY IMAGES.
[Retina]
2016.08DIAGNOSIS OF TYPE 3 NEOVASCULARIZATION BASED ON OPTICAL COHERENCE TOMOGRAPHY IMAGES
[RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES]
2016.08"Intravitreal Anti-vascular Endothelial Growth Factor for Treating Polypoidal Choroidal Vasculopathy with Grape-like Polyp Clusters "
[Korean J Ophthalmol]
2016.07Radiating hemorrhage in exudative age-related macular degeneration.
[Jpn J Ophthalmol]
2016.06Polypoidal choroidal vasculopathy in patients aged less than 50 years: characteristics and 6-month treatment outcome
[Graefes Arch Clin Exp Ophthalmol]
2016.06아플리버셉트 주사 후 발생한 비감염성 안내염
[대한안과학회지]
2016.06당뇨망막병증 수술 중 과도한 레이저술 후 발생한 장액망막박리에서 전신 스테로이드 치료 2예
[대한안과학회지]
2016.06Optical Coherence Tomography-based Diagnosis of Polypoidal Choroidal Vasculopathy in Korean Patients
[Korean J Ophthalmol]
2016.03Short-term choroidal thickness changes in patients treated with either ranibizumab or aflibercept: a comparative study.
[Br J Ophthalmol]
2016.03Twelve-month outcomes of treatment using ranibizumab or aflibercept for neovascular age-related macular degeneration: a comparative study.
[Graefes Arch Clin Exp Ophthalmol]
2016.03Long-Term Outcomes of Anti-Vascular Endothelial Growth Factor Therapy for Polypoidal Choroidal Vasculopathy
[J Ocul Pharmacol Ther]
2016.02Fellow-eye neovascularization in unilateral retinal angiomatous proliferation in a Korean population
[Acta Ophthalmol]
2016.01Self-recognition of recurrences among patients with exudative age-related macular degeneration
[Clin Exp Optom]
2016.01Self-recognition of recurrences among patients with exudative age-related macular degeneration
[CLINICAL AND EXPERIMENTAL OPTOMETRY]
2016.01Long-Term Outcome and Recurrence of Idiopathic Choroidal Neovascularization Treated with Intravitreal Bevacizumab
[JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS]
2016스펙트럼 영역 빛간섭단층촬영을 이용한 한국인의 연령과 성별에 따른 황반부 층별 두께 연구
[대한안과학회지]
2015.12PREVALENCE OF SUBTYPES OF RETICULAR PSEUDODRUSEN IN NEWLY DIAGNOSED EXUDATIVE AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY IN KOREAN PATIENTS.
[Retina]
2015.12PREVALENCE OF SUBTYPES OF RETICULAR PSEUDODRUSEN IN NEWLY DIAGNOSED EXUDATIVE AGE-RELATEDMACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY IN KOREAN PATIENTS
[RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES]
2015.12비외상성 비당뇨병성 유리체 출혈환자에서 유리체 절제술을 통한 원인 질환 분석
[대한안과학회지]
2015.10Clinical Outcomes of Eyes with Submacular Hemorrhage Secondary to Age-related Macular Degeneration Treated with Anti-vascular Endothelial Growth Factor.
[Korean J Ophthalmol]
2015.10Clinical Outcomes of Eyes with Submacular Hemorrhage Secondary to Age-related Macular Degeneration Treated with Anti-vascular Endothelial Growth Factor
[Korean Journal of Ophthalmology]
2015.0814세 여아에서 발생한 다발성 소실성 흰 점 증후군
[대한안과학회지]
2015.02Choroidal vascular hyperpermeability and punctate hyperfluorescent spot in choroidal neovascularization
[Invest Ophthalmol Vis Sci]
2015.02Choroidal Vascular Hyperpermeability and Punctate Hyperfluorescent Spot in Choroidal Neovascularization
[INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE]
2014.12Intravitreal anti-vascular endothelial growth factor for typical exudative age-related macular degeneration in eyes with good baseline visual acuity
[Korean J Ophthalmol]
2014.10Factors influencing the exudation recurrence after cataract surgery in patients previously treated with anti-vascular endothelial growth factor for exudative age-related macular degeneration.
[Graefes Arch Clin Exp Ophthalmol]
2014.10Factors influencing the exudation recurrence after cataract surgery in patients previously treated with anti-vascular endothelial growth factor for exudative age-related macular degeneration
[GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY]
2014.09당뇨황반부종 환자에서 이미지 압축이 빛간섭단층촬영 결과 해석에 미치는 영향
[대한안과학회지]
2014.09당뇨황반부종 환자에서 이미지 압축이 빛간섭단층촬영 결과해석에 미치는 영향
[대한안과학회지]
2014.04Intravitreal anti-vascular endothelial growth factor for submacular hemorrhage from choroidal neovascularization
[Ophthalmology]
2014.04Intravitreal Anti-Vascular Endothelial Growth Factor for Submacular Hemorrhage from Choroidal Neovascularization
[OPHTHALMOLOGY]
2013.12Effects of choroidal vascular hyperpermeability on anti-vascular endothelial growth factor treatment for polypoidal choroidal vasculopathy
[Am J Ophthalmol]
2008.12A case of an asymptomatic intralenticular foreign body
[Korean J Ophthalmol]
2008.12Effect of muscle relaxants on short-term results of exotropia surgery: a focus on resection procedures
[Korean J Ophthalmol]
2008.03안내충전물로서 과불화탄소액을 이용한 거대 망막열공이 동반된 망막박리 환자 치료 증례 1예
[대한안과학회지]